Biomerica (BMRA) Total Liabilities (2011 - 2026)

Biomerica has disclosed Total Liabilities across 16 years of filings, most recently posting $1.6 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $1.6 million, down 15.26% year-over-year; the trailing twelve-month figure through Feb 2026 was $1.6 million (down 15.26% YoY), and the FY2025 annual result was $1.8 million, down 30.9% from the prior year.
• Total Liabilities came in at $1.6 million for Q1 2026 at Biomerica, down from $1.6 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $7.8 million in Q1 2022 to a low of $1.6 million in Q1 2026.
• The 5-year median for Total Liabilities is $2.5 million (2023), against an average of $2.6 million.
• Across the five-year window, Total Liabilities surged 183.92% in 2022 and sank 71.5% in 2023, its largest moves.
• Biomerica's Total Liabilities stood at $2.7 million in 2022, then declined by 8.13% to $2.4 million in 2023, then decreased by 11.76% to $2.2 million in 2024, then slipped by 25.97% to $1.6 million in 2025, then slipped by 2.38% to $1.6 million in 2026.
• The last three Total Liabilities figures came in at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.